In: Vaccines, 2021, vol. 9, no. 9, p. 7
Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase with COVID-19 vaccines (of any technologies) than with other viral vaccines, over the full...
|
In: Journal of Neurology, 2015, vol. 262, no. 4, p. 870-880
|
In: Human Molecular Genetics, 2016, vol. 25, no. 5, p. 853-865
|
In: Journal of General Internal Medicine, 2015, vol. 30, no. 8, p. 1193-1203
|
In: Journal of Inherited Metabolic Disease, 2015, vol. 38, no. 6, p. 1075-1083
|
In: Journal of Inherited Metabolic Disease, 2015, vol. 38, no. 5, p. 957-967
|
In: Cell Systems, 2020, vol. 11, no. 6, p. 557-572.e5
Temporal interference (TI) is a non-invasive neurostimulation technique that utilizes high-frequency external electric fields to stimulate deep neuronal structures without affecting superficial, off-target structures. TI represents a potential breakthrough for treating conditions, such as Parkinson’s disease and chronic pain. However, early clinical work on TI stimulation was met with mixed...
|
In: New Zealand Journal of Ecology, 2020, vol. 44, no. 1, p. -
According to the most recent (2005) compendium on the history of the European hedgehog (Erinaceus europaeus) in New Zealand, this small insectivorous mammal was first brought from Europe to the South Island in the 19th century. This introduction has been presumed to be the source of hedgehogs that subsequently spread to the North Island. This view was informed by the absence of hedgehogs in...
|
In: PLOS genetics, 2019, vol. 15, no. 4, p. e1008069
In the peripheral nervous system (PNS) myelinating Schwann cells synthesize large amounts of myelin protein zero (P0) glycoprotein, an abundant component of peripheral nerve myelin. In humans, mutations in P0 cause the demyelinating Charcot-Marie-Tooth 1B (CMT1B) neuropathy, one of the most diffused genetic disorders of the PNS. We previously showed that several mutations, such as the...
|
In: Plos one, 2011, vol. 6, no. 10, p. e25488
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtypes have recently been described. Three mAbs, HJ16, HGN194 and HK20, were obtained from patients within the HIV-1 cohort of the Institute of Tropical Medicine (ITM). Our aim was to generate immunization antibodies equivalent to those seen in plasma. Here, we describe the selection and...
|